about
Comparison of tetrazolium salt assays for evaluation of drug activity against Leishmania spp.Differential production of systemic and intralesional gamma interferon and interleukin-10 in nodular and ulcerative forms of Buruli disease.Frequency and distribution of mixed Plasmodium falciparum-vivax infections in French Guiana between 2000 and 2008.Prevalence and Distribution of Leishmania RNA Virus 1 in Leishmania Parasites from French GuianaUnraveling the genetic diversity and phylogeny of Leishmania RNA virus 1 strains of infected Leishmania isolates circulating in French GuianaPresence of Leishmania RNA Virus 1 in Leishmania guyanensis Increases the Risk of First-Line Treatment Failure and Symptomatic Relapse.Unresponsiveness of specific T cells to IL-12 is associated with active cutaneous leishmaniasis owing to Leishmania guyanensis.High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment.Two-dimensional gel analysis of midgut proteins of Anopheles stephensi lines with different susceptibility to Plasmodium falciparum infection.Transcripts of the malaria vector Anopheles gambiae that are differentially regulated in the midgut upon exposure to invasive stages of Plasmodium falciparum.Susceptibility of Mycobacterium ulcerans to a combination of amikacin/rifampicin.In Vitro Sensitivity of Cutaneous Leishmania Promastigote Isolates Circulating in French Guiana to a Set of Drugs.[Diagnosis of Mycobacterium ulcerans infections in French Guiana].Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12
P50
Q33703500-E11CCD57-F119-48EE-BD72-6CF0D8793F6CQ35549819-0FF743C2-03CD-44FA-855A-73B8C6970370Q36270371-2A61B578-0579-413D-97AA-B311C6F9DA4BQ36455733-A85997DE-B62E-409F-93A3-DE755975316DQ38675651-E7A340FB-2E27-42B9-AB80-2E82013E7B4FQ41132309-590016F4-380B-4596-9290-89E0F232D734Q43530739-13678146-BCA3-411A-8B8A-2A5E17DA4F29Q43820711-F2A38498-65A5-4F17-9DEA-8770AFE9B7C0Q44139587-38623E06-2B3D-4028-9ED4-78201D0C3A3CQ44145952-A505D3A3-294A-473A-A0B9-A0A130F7E380Q44682716-22E384A4-593D-49F1-96C0-4C20192B95CFQ53522202-7F406378-BD64-43C8-8254-2588606D5859Q54688112-704CE209-8655-49A1-8C1D-A9F50F01DCCCQ73585346-CB04277D-E796-4BE7-8752-49CF2B97D698
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ghislaine Prevot
@ast
Ghislaine Prevot
@en
Ghislaine Prevot
@es
Ghislaine Prevot
@nl
Ghislaine Prevot
@sl
type
label
Ghislaine Prevot
@ast
Ghislaine Prevot
@en
Ghislaine Prevot
@es
Ghislaine Prevot
@nl
Ghislaine Prevot
@sl
prefLabel
Ghislaine Prevot
@ast
Ghislaine Prevot
@en
Ghislaine Prevot
@es
Ghislaine Prevot
@nl
Ghislaine Prevot
@sl
P106
P1153
7005715034
P31
P496
0000-0002-7268-4953